View Archived Issues

April 26, 2019

Vol. 18
No. 80


Amgen, Astellas Pay $125 Million to Settle Federal Kickback Allegations

Amgen and Astellas Pharma have agreed to pay nearly $125 million to settle federal allegations that they exploited charities to protect the prices of their favored drugs. Read More

PhRMA Says ‘Status Quo Must Change’ on Diabetes Prices

PhRMA, pressed on all sides by critics of its members’ insulin-pricing policies, on Thursday made its public pitch to be part of the solution and not just the problem. Read More

New Jersey API Maker Cited for Drug Quality Concerns

A Pennsville, New Jersey API manufacturer earned itself a Form 483 for quality violations at its facility, including failure to reject faulty drug substances and inadequate investigations of discrepancies. Read More